Genzyme calls 3% convertibles

New York, May 20 - Genzyme Corp. said it will redeem all its outstanding 3% convertible subordinated debentures due 2021 on June 1.

The Cambridge, Mass., biotechnology company will fund the redemption from its December 2003 sale of 1.25% convertible subordinated notes.

Genzyme issued $575 million of the 3% convertibles in May 2001.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.